Episode Details
Back to Episodes
Episode 524: ESMO 2026 - JNJ-6143, a Novel RIPTAC in mCRPC
Published 2 days, 2 hours ago
Description
Ben Garmezy discusses the phase 1 data of a novel mechanism in CRPC. This RIPTAC (Regulated Induced Proximity TargetingChimera) Molecule uses AR to enter the prostate cancer cell and inhibits BRD4 to interfere with cell transcription.